160 Atul Ltd | Annual Report 2021-22 Note 28.4 Related party disclosures (continued) (` cr) Note 28.4 (B) Transactions with subsidiary companies 2021-22 2020-21 Atul Middle East FZ-LLC 2.24 1.70 Atul USA Inc 0.84 0.41 5. Reimbursement of expenses 8.72 7.61 Aaranyak Urmi Ltd (current year: ` 8,326) 0.06 Amal Ltd 0.01 0.02 Atul Biospace Ltd (current year: ` 1,440) - Atul Bioscience Ltd - 0.10 Atul Brasil Quimicos Ltda 0.01 4.64 Atul China Ltd 0.10 0.72 Atul Crop Care Ltd 5.26 0.06 Atul Europe Ltd 0.75 - Atul Homecare Ltd (formerly known as Lapox Polymers Ltd) 1.88 1.87 Atul Middle East FZ-LLC - 0.10 Atul Products Ltd 0.29 - Atul USA Inc 0.42 0.04 c) Other transactions 1. Repayment of loans given 6.76 - Atul Bioscience Ltd 6.76 - 2. Direct investment made in equity shares 17.98 5.12 Atul Finserv Ltd 12.89 5.12 Atul Healthcare Ltd 0.10 - Atul Lifescience Ltd (previous year: ` 49,940) - Atul Products Ltd 4.99 - 3. Reimbursements received 0.03 - Aaranyak Urmi Ltd (current year: ` 6,276 and previous year: ` 1,100) Amal Ltd (current year: ` 39,731) - Atul Bioscience Ltd ( previous year: ` 45) 0.01 Atul Products Ltd 0.02 - Osia Infrastructure Ltd (current year: ` 5,527 and previous year: ` 15,006) 4. Redemption of preference shares 2.00 2.00 Amal Ltd 2.00 2.00 5. Loan given 290.23 6.50 Atul Bioscience Ltd 36.83 6.50 Atul Products Ltd 253.40 - 6. Extension of loan given - 17.50 Atul Bioscience Ltd - 17.50 7. Sale of fixed assets 0.01 0.23 Atul Bioscience Ltd 0.01 0.23 Atul Biospace Ltd (previous year: ` 5,294) - 8. Purchase of investment - 0.01 Atul Biospace Ltd - 0.01
RkJQdWJsaXNoZXIy MjA2MDI2